Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Yes.
The relationship of age with the clinical phenotype in multiple sclerosis.
Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
New clinical insights into combined central and peripheral demyelination (CCPD).
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.
Contralateral recurrence of tumefactive demyelination.
A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
Multiparity in women with multiple sclerosis causes less long-term disability: Yes.
Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Prevalence and incidence of Multiple Sclerosis in Campobasso (Molise region chieftown, southern Italy).
Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Errors in the Byline, Author Affiliations, and Author Contributions in: Long-term Follow-up of Acute Partial Transverse Myelitis.
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
Tricarboxylic acid cycle-sustained oxidative phosphorylation in isolated myelin vesicles.
Validity and reliability of the FSS in Greek MS patients.
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Pages
« first
‹ previous
…
600
601
602
603
604
605
606
607
608
…
next ›
last »